21 53

Cited 0 times in

Clinical and Radiographic Features of Peri-Implant Medication-Related Osteonecrosis of the Jaw: A Retrospective Study

DC Field Value Language
dc.contributor.author김준영-
dc.contributor.author박원서-
dc.contributor.author정영수-
dc.contributor.author차인호-
dc.date.accessioned2025-05-02T00:08:55Z-
dc.date.available2025-05-02T00:08:55Z-
dc.date.issued2025-02-
dc.identifier.issn1523-0899-
dc.identifier.urihttps://ir.ymlib.yonsei.ac.kr/handle/22282913/205293-
dc.description.abstractIntroduction: This study aimed to analyze the factors affecting the occurrence of peri-implant medication-related osteonecrosis of the jaw (PI-MRONJ) in patients using anti-resorptive drugs (ARDs) on different implant position, inclinations, and types of prosthesis. Methods: The data of 75 patients with bone necrosis that progressed around the implant between 2018 and 2022 were retrospectively examined to identify the factors influencing PI-MRONJ. Data, including patient demographics (age, sex, smoking status, concomitant disease, time of ARD therapy, dose of ARDs, and parafunctional habits) and implant-specific information (type of prosthesis, angle of insertion), were extracted from medical and dental records. Results: Tilted implants with an angle ≥ 5.1° relative to the occlusal plane of the prosthesis had a stronger association with PI-MRONJ in comparison to non-tilted implants (inclination was < 5°). Additionally, the boundary of the area of osteonecrosis around the fixture was larger for the splinted implant-supported crowns than for the single implant supported crowns). Conclusion: In patients taking anti-resorptive medications the inclination of the implant was associated with the occurrence of PI-MRONJ. Further studies are required to confirm the clinical findings.-
dc.description.statementOfResponsibilityopen-
dc.languageEnglish-
dc.publisherJohn Wiley & Sons, Inc-
dc.relation.isPartOfCLINICAL IMPLANT DENTISTRY AND RELATED RESEARCH-
dc.rightsCC BY-NC-ND 2.0 KR-
dc.subject.MESHAdult-
dc.subject.MESHAged-
dc.subject.MESHAged, 80 and over-
dc.subject.MESHBisphosphonate-Associated Osteonecrosis of the Jaw* / diagnostic imaging-
dc.subject.MESHBisphosphonate-Associated Osteonecrosis of the Jaw* / etiology-
dc.subject.MESHBone Density Conservation Agents* / adverse effects-
dc.subject.MESHDental Implants* / adverse effects-
dc.subject.MESHFemale-
dc.subject.MESHHumans-
dc.subject.MESHMale-
dc.subject.MESHMiddle Aged-
dc.subject.MESHRetrospective Studies-
dc.subject.MESHRisk Factors-
dc.titleClinical and Radiographic Features of Peri-Implant Medication-Related Osteonecrosis of the Jaw: A Retrospective Study-
dc.typeArticle-
dc.contributor.collegeCollege of Dentistry (치과대학)-
dc.contributor.departmentDept. of Oral and Maxillofacial Surgery (구강악안면외과학교실)-
dc.contributor.googleauthorHyeon-Gyu Jo-
dc.contributor.googleauthorWonse Park-
dc.contributor.googleauthorIn-Ho Cha-
dc.contributor.googleauthorYoung-Soo Jung-
dc.contributor.googleauthorDa Yun Lee-
dc.contributor.googleauthorJun-Young Kim-
dc.identifier.doi10.1111/cid.13412-
dc.contributor.localIdA05594-
dc.contributor.localIdA01589-
dc.contributor.localIdA03655-
dc.contributor.localIdA04002-
dc.relation.journalcodeJ00580-
dc.identifier.eissn1708-8208-
dc.identifier.pmid39506195-
dc.subject.keywordanti‐resorptive drugs-
dc.subject.keyworddental implant-
dc.subject.keywordjaw-
dc.subject.keywordosteonecrosis-
dc.contributor.alternativeNameKim, Jun-Young-
dc.contributor.affiliatedAuthor김준영-
dc.contributor.affiliatedAuthor박원서-
dc.contributor.affiliatedAuthor정영수-
dc.contributor.affiliatedAuthor차인호-
dc.citation.volume27-
dc.citation.number1-
dc.citation.startPagee13412-
dc.identifier.bibliographicCitationCLINICAL IMPLANT DENTISTRY AND RELATED RESEARCH, Vol.27(1) : e13412, 2025-02-
Appears in Collections:
2. College of Dentistry (치과대학) > Dept. of Oral and Maxillofacial Surgery (구강악안면외과학교실) > 1. Journal Papers
2. College of Dentistry (치과대학) > Dept. of Advanced General Dentistry (통합치의학과) > 1. Journal Papers

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.